Molecular imaging developer Sofie Biosciences has raised $5 million in financing from a group of investors.
Tata Industries, through its wholly owned subsidiary, led the series A round, along with other existing investors including MRM Capital and the Cycad Group. The funds will be used to further develop technologies to reduce the cost and complexity of PET, while also increasing the modality's availability and application base.
One of the most promising developments is a self-shielded microfluidic chip-based synthesizer for on-demand PET probe production, Sofie said.
